Australia Loop Diuretic Market Size & Outlook, 2025-2033

Australia Loop Diuretic Market Insights

As highlighted in Reed Intelligence analysis, the Australia Loop Diuretic Market, worth USD 53.5 Million in 2024, is forecasted to achieve USD 75.28 Million by 2033.
The Australia market is anticipated to grow at a CAGR of 3.82% during the period 2026–2033.
By 2024, Furosemide represented the largest share of the Type market size.
Bumetanide is expected to remain the key growth driver within Type, registering the fastest CAGR during the forecast period.

Other Key Findings

In 2024, Australia accounted for 0.79% of the global Loop Diuretic Market size.
By 2033, United States is expected to lead the global Loop Diuretic Market in terms of market size.
Within Asia Pacific, China is projected to dominate the regional Loop Diuretic Market size by 2033.
China is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 572.66 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 53.5 Million
Market Size In 2033	USD 75.28 Million
Largest segment	Furosemide
Units	Revenue in USD Million
CAGR	3.82% (2025-2033)
Segmnetation Covered
Type	Furosemide Bumetanide Torsemide Ethacrynic Acid
Indication	Heart Failure Hypertension Edema Renal Disorders
Route of Administration	Oral Intravenous Intramuscular
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Australia Loop Diuretic Market Type 2025-2033 (USD Million)

Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Furosemide	XX.x	XX.x	XX.x	22.06	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Bumetanide	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Torsemide	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Ethacrynic Acid	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Australia Loop Diuretic Market Indication 2025-2033 (USD Million)

Indication	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Heart Failure	XX.x	XX.x	XX.x	21.43	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Hypertension	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Edema	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Renal Disorders	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Australia Loop Diuretic Market Route of Administration 2025-2033 (USD Million)

Route of Administration	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Oral	XX.x	XX.x	XX.x	24.08	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Intravenous	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Intramuscular	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.